AML1-ETO targeted neoantigen cytotoxic T cells (CTL)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AML1-ETO targeted neoantigen cytotoxic T cells (CTL), covering 2025-08-28 to 2025-08-28. Get the full timeline:
Most recent: Clinical Trial Update: Treatment of Relapsed or Refractory t(8; 21) AML With Targeted AML1-ETO Neoantigen Cytotoxic T Cells (CTL) [EARLY_Phase 1]